LuciSelin (Selinexor) 20mg Tablets — XPO1 Inhibitor for Multiple Myeloma & DLBCL | Laos | GLT

REQUEST A QUOTE

For individuals and institutions — pricing, availability, and product documents (COA) provided within 24 hours.
Direct line: [email protected] · +86 15234153837

Share
Product description

Generic Information: LuciSelin (Selinexor) — Laos Generic

LuciSelin is a generic version of selinexor, the first-in-class oral XPO1 inhibitor, manufactured by Lucius Pharmaceuticals of Laos. It contains the same active pharmaceutical ingredient as the originator Xpovio and targets the same nuclear-export pathway, offered at a generic-market price that dramatically lowers the cost of selinexor therapy. LuciSelin is supplied as 20 mg tablets, with a larger 20 mg × 32 tablets pack size that suits the multi-week dosing schedules used in multiple myeloma.

Lucius Pharmaceuticals is an established Laos-based manufacturer whose products are registered in Laos and widely distributed across Southeast Asia, providing a reliable generic source for the unique XPO1-inhibitor mechanism.

What Is LuciSelin (Selinexor) 20 mg?

LuciSelin is an oral tablet containing 20 mg of selinexor per tablet, produced by Lucius Pharmaceuticals in Laos. As a generic, it matches the originator in active ingredient and therapeutic mechanism while being priced for broader accessibility. The product is supplied in a 20 mg × 32 tablets pack, a convenient size for the weekly dosing regimens of selinexor.

How Does LuciSelin (XPO1 Inhibitor) Work?

The active ingredient in LuciSelin, selinexor, selectively inhibits XPO1, the nuclear export protein that cancer cells exploit to dispose of tumor-suppressor proteins. Blocking XPO1 traps suppressors such as p53 in the nucleus, restoring their ability to stop cell division and induce apoptosis in malignant plasma cells. Because this mechanism is orthogonal to proteasome inhibition, IMiDs, and anti-CD38 therapy, selinexor works in patients whose disease has progressed on those standard classes.

Indications for LuciSelin (Selinexor)

  • Relapsed or refractory multiple myeloma (RRMM), including disease refractory to proteasome inhibitors, immunomodulatory agents, and an anti-CD38 monoclonal antibody.
  • Multiple myeloma in combination with bortezomib and dexamethasone after at least one prior line of therapy.
  • Relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL).

Dosage of LuciSelin (Selinexor) 20 mg Tablets

LuciSelin follows the standard selinexor dosing: 100 mg once weekly in the XVd regimen, or 80 mg on Days 1 and 3 of each week with dexamethasone alone. With 20 mg tablets, a 100 mg weekly dose requires five tablets. The 32-tablet box therefore covers a meaningful portion of a treatment cycle, and the treating physician adjusts dosing based on blood counts and side effects.

Side Effects of Selinexor (LuciSelin)

As with all selinexor products, the key toxicities are thrombocytopenia and neutropenia, which call for regular blood-count checks. Gastrointestinal effects — nausea, vomiting, diarrhea, anorexia, and weight loss — are common and may require supportive care. Hyponatremia, infections, and neurological symptoms such as dizziness can occur. Patients should not drive until they know how they respond to the drug.

Storage of LuciSelin Tablets

Store LuciSelin at room temperature in its original packaging, protected from moisture, heat, and direct light. Keep the tablets in the blister until immediately before use and out of the reach of children.

Why Choose the GLT?

LuciSelin from Lucius Pharmaceuticals offers a low-cost generic path to selinexor, priced several times cheaper than the originator Xpovio whose Western list price reaches the tens of thousands of dollars per treatment cycle. This price gap means a patient can access the same XPO1-inhibition mechanism for a fraction of the originator cost. GIVE LIFE TIME LIMITED (GLT) verifies the manufacturer, registration, and authenticity of every generic we supply, so institutional and individual buyers receive a genuine product with confidence.

How to Order LuciSelin (Selinexor) from Laos

To order LuciSelin (selinexor 20 mg) from Lucius Pharmaceuticals, contact GIVE LIFE TIME LIMITED (GLT). We serve hospital procurement, licensed pharmacy wholesalers, physician buyers, and individual patients. Reach us on WhatsApp at +86 15234153837 or email [email protected] for current pricing and delivery details.

FAQ: LuciSelin (Selinexor) Generic

Q: Is LuciSelin the same drug as Xpovio?
A: LuciSelin is a generic of selinexor, the same active ingredient in Xpovio, working by the same XPO1-inhibition mechanism but manufactured by Lucius Pharmaceuticals in Laos.

Q: Who makes LuciSelin?
A: LuciSelin is manufactured by Lucius Pharmaceuticals, a Laos-based pharmaceutical company with a broad portfolio of oncology generics.

Q: What is the pack size of LuciSelin?
A: LuciSelin is supplied as 20 mg × 32 tablets per box, a convenient size for selinexor's weekly dosing.

Q: What conditions does LuciSelin treat?
A: Relapsed/refractory multiple myeloma and relapsed/refractory diffuse large B-cell lymphoma.

Q: How do I order LuciSelin?
A: Contact GLT on WhatsApp +86 15234153837 or email [email protected] for availability and shipping information.

Related Oncology Products

Eltrombopag (Promacta) 25mg/50mg Tablets | US Originator TPO-R Agonist | GLT

Novartis originator Promacta (eltrombopag) 25mg & 50mg, 30 tablets

Orforglipron (LuciOrfor) 0.8–17.2mg Tablets | Laos Generic Oral GLP-1 | GLT

Lucius Pharmaceuticals (Laos) generic orforglipron, 6-dose titration for weight management

Tixepa (Tirzepatide) 20mg/2mL & 30mg/2mL Multi-Dose Pen | Drug International | GLT

Tixepa — Drug International Limited (DIL) tirzepatide multi-dose pen, two official strengths (Tixepa-5 = 20mg/2mL,...

XinKePing 欣可平 (Avatrombopag) 20mg*10 Tablets | Nanjing Hencer China | GLT

XinKePing — API-plus-tablet integrated avatrombopag from Nanjing Hencer Pharmaceutical (Jemcare group), China Mainland

KangQuXin 康曲欣 (Avatrombopag) 20mg*10 Tablets | Beijing Continent Gyre | GLT

KangQuXin — avatrombopag by Beijing Continent Pharmaceutical (Gyre Therapeutics, Nasdaq: GYRE), China Mainland

Olumiant (Baricitinib) 2mg/4mg Tablets | JAK1/JAK2 Inhibitor | Eli Lilly USA | GLT

Eli Lilly's selective JAK1/JAK2 inhibitor for rheumatoid arthritis, atopic dermatitis and severe alopecia areata.

SPINRAZA (Nusinersen) 12mg/5mL | Buy from China | SMA Therapy | GLT

Biogen's first-in-class antisense oligonucleotide for SMA, NMPA-approved and nationally reimbursed in China — buy from...

Mounjaro KwikPen (Tirzepatide) 10–60mg/2.4mL Multi-Dose | Eli Lilly USA | GLT

Mounjaro KwikPen — Eli Lilly single-patient multi-dose pen, six US strengths (10–60mg/2.4mL, 4 doses each)...